Processa Pharmaceuticals Inc (NAS:PCSA)
$ 1.63 -0.01 (-0.61%) Market Cap: 4.66 Mil Enterprise Value: -4.09 Mil PE Ratio: 0 PB Ratio: 0.52 GF Score: 30/100

Q2 2021 Processa Pharmaceuticals Inc Earnings Call Transcript

Aug 12, 2021 / 09:30PM GMT
Release Date Price: $117 (+1.39%)
Operator

Greetings and welcome to Processa Pharmaceuticals second-quarter 2021 earnings conference call and corporate update. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (Operator Instructions)

As a reminder, this conference call is being recorded. It is now my pleasure to introduce Jim Stanker, Chief Financial Officer. Thank you, sir. You may begin.

Jim Stanker
Processa Pharmaceuticals, Inc. - CFO

Thank you and welcome to Processa's second-quarter 2021 quarterly results and drug development update conference call.

Joining me on the call today are our Chief Executive Officer, Dr. David Young; and our Chief Operating Officer, Mike Floyd. Shortly before this call, we filed our second-quarter Form 10-Q. I want to remind everyone that a PowerPoint presentation will accompany Dr. Young's prepared remarks. To view the PowerPoint slides, please go to the earnings press release and click on the webcast link to follow along.

I will start our call by reading the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot